• No results found

Pancreatic Cancer

N/A
N/A
Protected

Academic year: 2022

Share "Pancreatic Cancer"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

David Ljungman Pancreatic Cancer Experimental and Clinical Studies

Pancreatic Cancer

– Experimental and Clinical Studies

2013

ISBN 978-91-628-8729-2

Printed by Ineko AB, Gothenburg

David Ljungman

Institute of Clinical Sciences at Sahlgrenska Academy University of Gothenburg

References

Related documents

The overall aim of this thesis is to establish a platform for translational pancreatic cancer research to enable detection of potential tumor markers, evaluation

A translational platform for pancreatic cancer research, that enable studies of tumor biology, prognostic biomarkers, new therapies and detection of postoperative complications

ISBN 978-91-8009-342-2 (PRINT) ISBN 978-91-8009-343-9 (PDF) Printed by Stema Specialtryck AB, Borås. T ranslational and clinical aspects of pancreatic cancer | Caroline V

In
PDAC
the
dismal
prognosis
even
after
resection
with
curative
aim
together
with
a
 substantial
 procedure‐related
 morbidity
 has
 nurtured
 a


Conclusions Proteasome
inhibition
is
a
promising
adjunct
in
horizontal
targeted
therapy
regimens
 and
 the
 effect
 may
 be
 potentiated
 by


performs miRNA target prediction, functional enrichment analysis and in silico evaluation of predicted miRNA-mRNA pairs by correlation of miRNA expression levels to its targets on

16.5 Combining stromal and cell derived biomarkers in PDAC Circulating levels of the stromal components Col IV, Endostatin, OPN and TNC were measured and compared

To evaluate the novel oncolytic virus LOAd703’s capacity to kill pancreatic cancer cell but sparing normal cells, to activate human immune cells, and if gemcitabine will enhance